HSTA: AI 评分 39/100 — AI 分析 (4月 2026)

Hestia Insight Inc. is a strategic consulting and capital market advisory firm focused on micro, small, and medium-sized companies. The company also offers healthcare management, technology development, and sales support services, primarily operating within the healthcare, biotech, and fintech sectors.

Key Facts: AI Score: 39/100 Sector: Technology

公司概况

概要：

Hestia Insight Inc. provides strategic consulting and capital market advisory services, primarily targeting micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors. Additionally, they offer healthcare management, technology development, and sales support, positioning them as a multifaceted service provider in specialized markets.

HSTA是做什么的？

Hestia Insight Inc., formerly known as Luxshmi Investments, Inc. until its name change in May 2019, is a Las Vegas-based firm providing strategic consulting and capital market advisory services. The company focuses on serving micro, small, and medium-sized enterprises within the healthcare, biotech, and fintech sectors. Hestia Insight offers a range of services, including healthcare management and patient services, development of healthcare technologies and analysis for neurological and psychiatric disorders, and medical supply sales support and management. The company also provides sales and marketing guidance to its clients. Hestia Insight's multifaceted approach aims to support its clients through various stages of growth and development, leveraging its expertise in both the financial and healthcare technology domains. The company operates with a small team of three employees.

HSTA的投资论点是什么？

Hestia Insight Inc. presents a unique investment proposition as a consulting and advisory firm operating at the intersection of healthcare, biotech, and fintech. The company's focus on micro, small, and medium-sized businesses allows it to cater to a niche market often underserved by larger consulting firms. Key value drivers include the potential for revenue growth through expansion of its service offerings and client base within its target sectors. However, the may be worth researching risks associated with the company's small size, limited resources, and dependence on key personnel. The company's P/E ratio is -0.78 and Beta is -0.31 as of March 16, 2026.

HSTA在哪个行业运营？

Hestia Insight Inc. operates within the competitive landscape of consulting and advisory services, specifically targeting the healthcare, biotech, and fintech sectors. These sectors are characterized by rapid innovation, evolving regulatory environments, and significant capital flows. The market for consulting services in these sectors is driven by the need for specialized expertise in areas such as regulatory compliance, technology adoption, and market access. Hestia Insight's focus on micro, small, and medium-sized businesses positions it to capitalize on the demand for tailored solutions in these dynamic industries.

Software - Application

Technology

HSTA有哪些增长机遇？

Expansion of Healthcare Technology Development: Hestia Insight can capitalize on the growing demand for innovative healthcare technologies by expanding its development capabilities. The global healthcare technology market is projected to reach $280 billion by 2028, presenting a significant opportunity for Hestia Insight to develop and commercialize new solutions for neurological and psychiatric disorders. Timeline: 2-3 years.
Strategic Partnerships with Fintech Companies: Collaborating with emerging fintech companies to provide specialized consulting services can drive growth. The fintech market is experiencing rapid growth, with a projected market size of $509 billion by 2029. Hestia Insight can leverage its expertise in capital markets and healthcare to offer valuable insights to fintech companies seeking to disrupt the healthcare industry. Timeline: 1-2 years.
Increased Focus on Healthcare Management Services: The demand for efficient healthcare management services is increasing as healthcare providers seek to optimize operations and improve patient outcomes. Hestia Insight can expand its healthcare management offerings to address this need, targeting micro and small healthcare providers that may lack the resources to implement sophisticated management systems. Timeline: Ongoing.
Geographic Expansion Beyond Las Vegas: Hestia Insight can explore opportunities to expand its geographic reach beyond Las Vegas, targeting other regions with a high concentration of healthcare, biotech, and fintech companies. This expansion can be achieved through strategic partnerships, remote service delivery, and the establishment of satellite offices. Timeline: 3-5 years.
Development of Proprietary Healthcare Analytics Platform: Creating a proprietary healthcare analytics platform can provide Hestia Insight with a competitive advantage and generate recurring revenue streams. This platform can leverage data analytics and machine learning to provide insights into patient behavior, treatment outcomes, and market trends, enabling healthcare providers to make more informed decisions. Timeline: 2-3 years.

Hestia Insight Inc. operates with a small team of 3 employees, indicating a lean operational structure.
The company's focus on micro, small, and medium-sized businesses in healthcare, biotech, and fintech allows for specialized service offerings.
Hestia Insight provides a diverse range of services, including strategic consulting, capital market advisory, healthcare management, and technology development.
The company's negative P/E ratio of -0.78 suggests that it is currently not profitable.
The company's beta of -0.31 indicates a low correlation with the overall market, potentially offering some downside protection.

HSTA提供哪些产品和服务？

Provides strategic consulting services to micro, small, and medium-sized companies.
Offers capital market advisory services.
Delivers healthcare management and patient services.
Develops healthcare technologies and analysis for neurological and psychiatric disorders.
Provides medical supply sales support and management.
Offers sales and marketing guidance and services.

HSTA如何赚钱？

Generates revenue through consulting fees for strategic advisory services.
Earns fees from capital market advisory services, such as assisting with fundraising and M&A transactions.
Derives income from healthcare management and patient service contracts.
Potentially generates revenue from the licensing or sale of developed healthcare technologies.

Micro-sized companies in the healthcare sector.
Small-sized businesses in the biotech industry.
Medium-sized enterprises in the fintech sector.

Specialized expertise in the intersection of healthcare, biotech, and fintech.
Focus on micro, small, and medium-sized businesses, a niche often underserved by larger firms.
Integrated service offerings spanning consulting, advisory, technology development, and sales support.

什么因素可能推动HSTA股价上涨？

Upcoming: Potential partnerships with fintech companies to expand service offerings in the fintech sector.
Ongoing: Increasing demand for healthcare technology solutions for neurological and psychiatric disorders.
Ongoing: Expansion of healthcare management services to address the needs of micro and small healthcare providers.

HSTA的主要风险是什么？

Potential: Limited financial resources may constrain growth initiatives and expansion plans.
Potential: Dependence on key personnel could disrupt operations if they leave the company.
Ongoing: Intense competition from larger consulting firms with greater resources and brand recognition.
Potential: Evolving regulatory landscape in healthcare and fintech may require costly compliance efforts.
Ongoing: OTC market listing may reduce investor confidence and limit access to capital.

HSTA的核心优势是什么？

Specialized focus on healthcare, biotech, and fintech sectors.
Integrated service offerings covering consulting, advisory, and technology development.
Agile and responsive due to small company size.
Established presence in Las Vegas.

HSTA的劣势是什么？

Limited financial resources and capital.
High dependence on key personnel.
Small team size may limit scalability.
OTC market listing may reduce investor confidence.

HSTA有哪些机遇？

Expansion into new geographic markets.
Development of proprietary healthcare technology solutions.
Strategic partnerships with complementary businesses.
Increased demand for specialized consulting services in target sectors.

HSTA面临哪些威胁？

Intense competition from larger consulting firms.
Evolving regulatory landscape in healthcare and fintech.
Economic downturn impacting client spending.
Technological disruptions rendering existing services obsolete.

HSTA的竞争对手是谁？

Aptinyx Inc. — Focuses on developing therapies for brain and nervous system disorders. — (APTY)
Enthusiast Gaming Holdings Inc. — Operates in the gaming and esports media sector. — (ENETF)
iSign Solutions of America, Inc. — Provides digital transaction management solutions. — (ISGIF)
Mysale Group PLC — Operates online retail businesses. — (MYSL)
North American Health Direct, Inc. — Focuses on direct-to-consumer health and wellness products. — (NAHD)

Key Metrics

MoonshotScore: 39/100

Company Profile

CEO: Edward C. Lee
Headquarters: Las Vegas, US
Employees: 3
Founded: 2009

AI Insight

AI analysis pending for HSTA

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Hestia Insight Inc. do?

Hestia Insight Inc. operates as a strategic consulting and capital market advisory firm, primarily serving micro, small, and medium-sized companies within the healthcare, biotech, and fintech sectors. The company offers a suite of services, including healthcare management, technology development for neurological and psychiatric disorders, and sales support. This multifaceted approach positions Hestia Insight as a comprehensive service provider, aiming to support its clients' growth and development through specialized expertise.

What do analysts say about HSTA stock?

As of March 16, 2026, there is no available analyst coverage for Hestia Insight Inc. (HSTA). Given its OTC Other listing and small market capitalization of $0.00B, the company does not attract significant attention from major brokerage firms or research institutions. Investors should conduct their own thorough due diligence and consider the risks associated with investing in thinly traded, micro-cap stocks with limited public information. The company's P/E ratio is -0.78 and Beta is -0.31.

What are the main risks for HSTA?

Hestia Insight Inc. faces several key risks, including its limited financial resources, dependence on key personnel, and intense competition from larger consulting firms. Its OTC Other listing presents additional risks related to limited liquidity, regulatory oversight, and financial disclosure. The evolving regulatory landscape in healthcare and fintech could also pose challenges, requiring costly compliance efforts. Investors should carefully consider these risks before investing in HSTA.